Petch L A, Hoffman I F, Jere C S, Kazembe P N, Martinson F E, Chilongozi D, Fiscus S A, Cohen M S
UNC Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
AIDS Res Hum Retroviruses. 2005 Sep;21(9):799-805. doi: 10.1089/aid.2005.21.799.
The protease (PR) and reverse transcriptase (RT) regions of HIV-1 isolates from 21 antiretroviral (ARV)-naive Malawian adults were sequenced and analyzed to determine the prevalence of drug resistance-associated mutations in this population. Phylogenetic analysis confirmed that all isolates grouped with HIV-1 subtype C, the predominant subtype in Malawi. No major mutations associated with resistance to PR inhibitors (PIs), nucleoside RT inhibitors (NRTIs), or nonnucleoside RT inhibitors (NNRTIs) were found. In contrast, accessory mutations were found in the protease region at positions 10, 20, 36, 63, 77, and 93, and in the RT region at positions 118, 211, and 214. Further studies will be needed to determine the clinical impact of these polymorphisms on viral susceptibility to existing antiretroviral drugs.
对21名未接受过抗逆转录病毒治疗(ARV)的马拉维成年患者的HIV-1分离株的蛋白酶(PR)和逆转录酶(RT)区域进行测序和分析,以确定该人群中与耐药相关突变的流行情况。系统发育分析证实,所有分离株均与HIV-1 C亚型聚类,C亚型是马拉维的主要亚型。未发现与对PR抑制剂(PIs)、核苷类RT抑制剂(NRTIs)或非核苷类RT抑制剂(NNRTIs)耐药相关的主要突变。相比之下,在蛋白酶区域的第10、20、36、63、77和93位以及RT区域的第118、211和214位发现了辅助突变。需要进一步研究以确定这些多态性对病毒对现有抗逆转录病毒药物易感性的临床影响。